Funding for this research was provided by:
Whitlam Joint Replacement Centre and Whitlam Orthopaedic Research Centre
Received: 15 July 2020
Accepted: 9 November 2020
First Online: 20 November 2020
Ethics approval and consent to participate
: The study was approved by the South West Sydney Ethics Committee (LNR/18/LPOOL/128). As per our ethical approval, participants were provided with a Participant Information Sheet (in multiple languages) about the quality improvement study prior to surgery and were asked to provide verbal informed consent for phone call follow up post discharge. Written consent was not considered necessary as the usual procedure for our hospital at the time was for patients to be routinely followed up via telephone several days post discharge by nursing staff and at 6 months by ACORN (the Arthroplasty Clinical Outcome Registry National). Written consent is not needed for either of these but patients are informed of the process. All patients were included in the acute-care phase as the protocol applied to all patients. Those providing verbal informed consent were followed-up after discharge. Patients were given the choice to opt out of being interviewed at the 4 week post discharge and again at the 12 week follow up phone call. A record of who agreed or declined to participate in the follow-up was kept by the study chief investigator in an Excel file that included patient screening and consent details.
: Not applicable.
: The authors declare that they have no competing interests.